Lekoil Limited (LEK) - Financial Analysis Review
Lekoil Limited (LEK) - Financial Analysis ReviewSummary
Lekoil Limited (Lekoil) is an oil and gas exploration and production company in Nigeria and Namibia. It owns four oil and gas exploration and production properties which include otakikpo and OPL 310 in Nigeria, block 2514 A and block 2514 B in Namibia. The company’s target portfolio includes Dahomey basin exploration and West Africa Niger. Lekoil’s otakikpo marginal field is located in swamp location in OML 11, adjacent to shoreline.
GlobalData's Lekoil Limited (LEK) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.
Lekoil Limited Key Recent Developments:
Jan 03,2017: Otakikpo Field Offshore Pipeline 80% Completed, Says Lekoil
Dec 08,2016: Lekoil Provides Otakikpo - Production Update
Sep 29,2016: Lekoil Reports Half Year Results For The Six Months To 30 June 2016
Sep 15,2016: LEKOIL Provides Operational Update And Increase Of FBN Facility
Jun 30,2016: Lekoil: New Debt Facility With Sterling Bank
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report include; revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.